Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

被引：36
|
作者：
Barreto, L.
Guasparini, R.
Meekison, W.
Noya, F.
Young, L.
Mills, E.
机构：
[1] Sanofi Pasteur Ltd, Toronto, ON M2R 3T4, Canada
[2] Fraser Hlth Authority, Surrey, BC V3X 3A4, Canada
[3] Westcoast Clin Res, Coquitlam, BC V3C 4J2, Canada
[4] Montreal Childrens Hosp, Div Infect Dis, Montreal, PQ H3H 1P3, Canada
来源：
VACCINE | 2007年 / 25卷 / 48期
关键词：
pertussis; vaccine; serology;
D O I：
10.1016/j.vaccine.2007.09.031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Persistence of antibodies following a single dose of Tdap, vaccine (tetanus, diphtheria, and five-component acellular pertussis vaccine for use in individuals past childhood) was evaluated in a follow-up of adolescents (N = 324) and adults (N = 644) who had received Tdap in earlier clinical trials. Outcome measures were seroprotection (tetanus and diphtheria) or seropositivity (pertussis) and geometric mean titers. Humoral immune responses to all antigens were robust 1 month after initial immunization; antibodies exceeded pre-immunization levels 1, 3, and 5 years later. These data will contribute to selecting the optimal interval for booster doses of Tdap. Crown Copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：8172 / 8179
页数：8
相关论文
共 50 条
  • [41] Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
    Knuutila, Aapo
    Barkoff, Alex-Mikael
    Ivaska, Lauri
    Tenhu, Elina
    Terasjarvi, Johanna
    van Gageldonk, Pieter
    Buisman, Annemarie
    Mertsola, Jussi
    He, Qiushui
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [42] Poor response to Hib (PRP-T) vaccine when combined with an acellular pertussis/diphtheria/tetanus vaccine for primary immunization of infants
    Bell, F
    Health, P
    Shackley, F
    Maclennan, J
    Herbert, M
    Shearstone, N
    Diggle, L
    Moxon, ER
    Finn, A
    BIOLOGICALS, 1999, 27 (02) : 113 - 113
  • [43] Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when administered concurrently with a pneumococcal conjugate vaccine: A randomized, open-label, phase 3 study
    Bernstein, Henry H.
    Noriega, Fernando
    VACCINE, 2011, 29 (11) : 2212 - 2221
  • [44] Erratum to Spotlight on Tdap5 Vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged ≥4 years), adolescents, and adults
    Lesley J. Scott
    Pediatric Drugs, 2011, 13 (3) : 174 - 174
  • [45] Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age
    Schmitt, HJ
    Beutel, K
    Schuind, A
    Knuf, M
    Wagner, S
    Muschenborn, S
    Bogaerts, H
    Bock, HL
    Clemens, R
    JOURNAL OF PEDIATRICS, 1997, 130 (04): : 616 - 623
  • [46] Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age
    Vergara, R
    Tregnaghi, M
    Ussher, J
    Navarro, S
    Rüttimann, R
    Potin, M
    Wolter, J
    Schuerman, L
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (06) : 377 - 382
  • [47] Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age
    Rodrigo Vergara
    Miguel Tregnaghi
    José Ussher
    Sofía Navarro
    Ricardo Rüttimann
    Marcela Potin
    Joanne Wolter
    Lode Schuerman
    European Journal of Pediatrics, 2005, 164 : 377 - 382
  • [48] STUDIES ON DIPHTHERIA-PERTUSSIS-TETANUS COMBINED IMMUNIZATION IN CHILDREN .3. IMMUNE RESPONSES AFTER THE BOOSTER VACCINATION
    CHEN, BL
    CHOW, CT
    HUANG, CT
    JOURNAL OF IMMUNOLOGY, 1957, 79 (05): : 393 - 400
  • [49] COMBINED IMMUNIZATION AGAINST DIPHTHERIA, TETANUS AND PERTUSSIS IN NEWBORN INFANTS .2. DURATION OF ANTIBODY LEVELS - ANTIBODY TITERS AFTER BOOSTER DOSE - EFFECT OF PASSIVE IMMUNITY TO DIPHTHERIA ON ACTIVE IMMUNIZATION WITH DIPHTHERIA TOXOID
    DISANTAGNESE, PA
    PEDIATRICS, 1949, 3 (02) : 181 - 194
  • [50] Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination
    McIntyre, Peter B.
    Burgess, Margaret A.
    Egan, Annemarie
    Schuerman, Lode
    Hoet, Bernard
    VACCINE, 2009, 27 (07) : 1062 - 1066
12345